NozTop Nasal Spray (Mometasone Furoate)

Adult dosage

For allergic rhinitis, adults (including the elderly) and adolescents aged 12 years and older typically receive 2 sprays in each nostril once daily (total daily dose of 0.2 mg). When symptoms are relieved, the maintenance dose can be reduced to 1 spray in each nostril (total daily dose of 0.1 mg). If symptoms are not alleviated, the dose can be increased to a maximum of 4 sprays in each nostril once daily (total daily dose of 0.4 mg), and symptoms.

Children's dosage

For allergic rhinitis, children aged 2-11 years typically receive 1 spray in each nostril once a day (total daily dose of 0.1 mg).

This medication should not be administered to certain patients. First, patients who are allergic to this drug or its components or have experienced hypersensitivity reactions should not use it. Patients with untreated infections of the nasal mucosa, those who have recently undergone nasal surgery, or those with nasal wounds should also avoid using this drug. It is particularly contraindicated in infants under 2 years of age. This medication should be used cautiously in some patients. Patients with active or latent tuberculosis, those with fungal or viral infections, patients who experience recurrent nosebleeds, and patients who may be exposed to varicella or measles should exercise caution. Pregnant women, nursing mothers, and patients with unilateral nasal polyps should also be careful when using this medication. When using this medication, side effects such as headaches, viral infections, pharyngitis, nosebleeds, cough, and other symptoms may occur. In particular, there is a possibility of bleeding from the nose, and rarely serious reactions such as allergic reactions or anaphylaxis can occur; if any unusual symptoms appear, the treatment should be stopped immediately and medical advice should be sought. Prolonged use at high doses may result in systemic corticosteroid side effects, so caution is necessary. If symptoms of infection, facial pain, or periorbital swelling appear, immediate consultation with a physician is advised. Long-term use of this medication may require regular monitoring of changes in the nasal mucosa, and if local fungal infections occur, it may be necessary to discontinue treatment or provide appropriate therapy. As there is a risk of exposure to infections such as varicella or measles, it is essential to confirm vaccination status and medical history before using this medication, and to seek medical attention promptly if an infection is suspected. In pediatric patients, this medication can affect growth rates, so regular growth monitoring is essential, and it is important to use the minimal effective dose. In the elderly, there may be a decline in physical function, so treatment should be conducted carefully while monitoring their status. In the case of overdose, specific treatment is generally not required, but the possibility of side effects from excessive use of corticosteroids should be considered. This medication should only be used intranasally, and the container should be shaken well before use and tested with a specific number of trial sprays before each use. Care should be taken not to spray directly into the eyes or on the nasal septum, and it should be stored out of reach of children after use.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, symptoms of anaphylaxis (shortness of breath, generalized flushing, angioedema, hives), nosebleeds, severe skin reactions (severe rash, blistering, skin peeling, pain in lips/eyes), liver abnormalities (yellowing of the skin or eyes, extreme lethargy), serious neurological symptoms (sudden and severe headache, thunderclap headache, seizures, confusion, vision abnormalities, paralysis), severe.

Mild side effects

Headache, viral infection, pharyngitis, nosebleed/blood-colored mucus, cough, upper respiratory infection, dysmenorrhea, musculoskeletal pain, sinusitis, vomiting, arthralgia, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, dyspepsia, otalgia, cold symptoms, myalgia, nausea, rhinitis, diarrhea, nasal inflammation, otitis media, wheezing, skin trauma, nasal symptoms (irritation, itching, dryness, pain, redness, discomfort), positive nasal fungal test, pharyngitis.

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is advisable to keep it at room temperature between 2 to 25 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance

An opaque suspension that is white or almost white in a container that dispenses a specific amount per spray.

Package unit

18g/bottle